Acetaminophen ototoxicity after acetaminophen/hydrocodone abuse: Evidence from two parallel in vitro mouse models

Otolaryngology - Head and Neck Surgery

Volumn 142, Issue 6, 2010, Pages

  Yorgason, Joshua G ^a   Kalinec, Gilda M ^b   Luxford, William M ^b   Warren, Frank M ^a   Kalinec, Federico ^b,c  

^a UNIVERSITY OF UTAH   (United States)

^b HOUSE EAR INSTITUTE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE; CASPASE 3; GREEN FLUORESCENT PROTEIN; HYDROCODONE; PARACETAMOL;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL SURVIVAL; COCHLEA; CONTROLLED STUDY; DRUG ABUSE; DRUG EXPOSURE; DRUG POTENTIATION; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HAIR CELL; HEARING LOSS; IN VITRO STUDY; MOUSE; NONHUMAN; OTOTOXICITY; SENSORY NERVE CELL;

EID: 77952289507     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2010.01.010     Document Type: Article

References (20)

1. Food and Drug Administration Center for Drug Evaluation and Research. June 29-30, 2009 Meeting of the Drug Safety and Risk Management Advisory Committee. http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/ucm126014.htm Accessed September 10, 2009
2. Friedman R.A., House J.W., Luxford W.M., et al. Profound hearing loss associated with hydrocodone/acetaminophen abuse. Am J Otol 21 (2000) 188-191
3. Ho T., Vrabec J.T., and Burton A.W. Hydrocodone use and sensorineural hearing loss. Pain Physician 10 (2007) 467-472
4. Oh A.K., Ishiyama A., and Baloh R.W. Deafness associated with abuse of hydrocodone/acetaminophen. Neurology 54 (2000) 2345
5. Ramsay B.C. Complete nerve deafness after abuse of co-proxamol. Lancet 338 (1991) 446-447
6. Lupin A.J., and Harley C.H. Inner ear damage related to propoxyphene ingestion [letter]. Can Med Assoc J 114 (1976) 596
7. Harell M., Shea J.J., and Emmett J.R. Total deafness with chronic propoxyphene abuse. Laryngoscope 88 (1978) 1518-1521
8. Blakley B.W., and Schilling H. Deafness associated with acetaminophen and codeine abuse. J Otolaryngol Head Neck Surg 37 (2008) 507-509
9. Doetzlhofer A., White P.M., Johnson J.E., et al. In vitro growth and differentiation of mammalian sensory hair cell progenitors: a requirement for EGF and periotic mesenchyme. Dev Biol 272 (2004) 432-447
10. Kalinec G.M., Webster P., Lim D.J., et al. A cochlear cell line as an in vitro system for drug ototoxicity screening. Audiol Neurootol 8 (2003) 177-189
11. Kalinec G., Fernandez Zapico M., Urrutia R., et al. Pivotal role of Harakiri in the induction and prevention of gentamicin-induced hearing loss. Proc Natl Acad Sci U S A 102 (2005) 16019-16024
12. Palangio M., Damask M.J., Morris E., et al. Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain. Clin Ther 22 (2000) 879-892
13. Rodriguez R.F., Castillo J.M., Del Pilar Castillo M., et al. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study. Clin Ther 29 (2007) 581-587
14. Mikus G., and Weiss J. Influence of CYP2D6 on opioid kinetics, metabolism and response. Curr Pharmacogenomics 3 (2005) 43-52
15. Corchero J., Granvil C.P., Akiyama T.E., et al. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse. Mol Pharmacol 60 (2001) 1260-1267
16. Bromer M.Q., and Black M. Acetaminophen hepatotoxicity. Clin Liver Dis 7 (2003) 351-367
17. Hersh E.V., Pinto A., and Moore P.A. Adverse drug interactions involving common prescription and over-the-counter analgesic agents. Clin Ther 29 suppl (2007) 2477-2497
18. Harman A.W., Kyle M.E., Serroni A., et al. The killing of cultured hepatocytes by N-acetyl-p-benzoquinone imine (NAPQI) as a model of the cytotoxicity of acetaminophen. Biochem Pharmacol 41 (1991) 1111-1117
19. Waring W.S., and Benhalim S. Serum acetaminophen concentrations after acute overdose are not altered by opioid co-ingestion. J Toxicol Sci 33 (2008) 549-553
20. Shayiq R.M., Roberts D.W., Rothstein K., et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology 29 (1999) 451-463